Biomet Lawsuit News: Federal Court Releases New Leadership Order, Notes Rottenstein Law Group LLP

The firm is actively filing Biomet Magnum M2a lawsuits on behalf of those who have suffered metallosis, premature device failure and other serious complications allegedly caused by the metal-on-metal hip device.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The firm is actively filing Biomet Magnum M2a lawsuits on behalf of those who have suffered metallosis, premature device failure, and other serious complications allegedly caused by the metal-on-metal hip device.

The firm is actively filing Biomet Magnum M2a lawsuits on behalf of those who have suffered metallosis, premature device failure, and other serious complications allegedly caused by the metal-on-metal

The plaintiffs’ steering committee helps direct the plaintiffs’ side of the MDL, which is necessary when there are many cases consolidated for efficiency in pretrial proceedings.

(PRWEB) December 09, 2013

A federal court in Indiana recently ordered a new deadline for the reappointment and appointment of individuals to the plaintiffs’ steering committee in the federal consolidation of Biomet lawsuits, according to court documents. The Rottenstein Law Group LLP, a metal-on-metal hip implant law firm that maintains a Biomet lawsuit informational website, discusses the news and how it could impact those who have filed or are looking to file Biomet lawsuits.

The plaintiffs steering committee deadline, Dec. 3, was outlined in a judicial order released on the same date, according to court documents (In re: Biomet M2A Magnum Hip Implant Products Liability Litigation; MDL-2391, U.S. District Court for the Northern District of Indiana). Judge Robert L. Miller, Jr., is overseeing the consolidation of federal cases into what is called a “multidistrict litigation.”

“The plaintiffs’ steering committee helps direct the plaintiffs’ side of the MDL, which is necessary when there are many cases consolidated for efficiency in pretrial proceedings,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.

There are about 800 Biomet lawsuits pending in federal court, stemming from claims that the company’s Magnum M2a hip implant caused patients to suffer from serious side effects. The Biomet product joins similar products from major manufacturers such as DePuy Orthopaedics and Stryker that have been involved in major litigation and fallen under the scrutiny of the U.S. Food and Drug Administration. Johnson & Johnson and its subsidiary DePuy have agreed to a multibillion dollar DePuy ASR settlement related to claims related to a high rate of revision surgeries, according to a Nov. 20 New York Times report.*

Plaintiffs in Biomet lawsuits have alleged a handful of complications, including pain, device failure and metal poisoning, according to court documents.

The Rottenstein Law Group LLP encourages those who believe they have suffered from the Biomet’s alleged side effects to visit its FAQ page to learn more about Biomet lawsuits and side effects, and how to contact an attorney for a free consultation.

*nytimes.com/2013/11/20/business/johnson-johnson-to-offer-2-5-billion-hip-device-settlement.html?_r=0

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
plus.google.com/106070664376281033016